These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19646797)
1. Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety. Manojkumar P; Ravi TK; Gopalakrishnan S Eur J Med Chem; 2009 Nov; 44(11):4690-4. PubMed ID: 19646797 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel formyl-pyrazoles bearing coumarin moiety as potent antimicrobial and antioxidant agents. Nagamallu R; Kariyappa AK Bioorg Med Chem Lett; 2013 Dec; 23(23):6406-9. PubMed ID: 24120538 [TBL] [Abstract][Full Text] [Related]
3. New series of antiprion compounds: pyrazolone derivatives have the potent activity of inhibiting protease-resistant prion protein accumulation. Kimata A; Nakagawa H; Ohyama R; Fukuuchi T; Ohta S; Doh-ura K; Suzuki T; Miyata N J Med Chem; 2007 Oct; 50(21):5053-6. PubMed ID: 17850126 [TBL] [Abstract][Full Text] [Related]
4. Antioxidant properties of 3-hydroxycoumarin derivatives. Bailly F; Maurin C; Teissier E; Vezin H; Cotelle P Bioorg Med Chem; 2004 Nov; 12(21):5611-8. PubMed ID: 15465339 [TBL] [Abstract][Full Text] [Related]
5. Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus. Xu P; Zhang YY; Sun YX; Liu JH; Yang B; Wang YZ; Wang YL Chem Biol Drug Des; 2009 Jun; 73(6):655-60. PubMed ID: 19635057 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and antibacterial activity of 2-[1-(5-chloro-2-methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-5-(substituted-phenyl)-[1,3,4]oxadiazoles. Rai NP; Narayanaswamy VK; Shashikanth S; Arunachalam PN Eur J Med Chem; 2009 Nov; 44(11):4522-7. PubMed ID: 19640616 [TBL] [Abstract][Full Text] [Related]
7. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity. Roussaki M; Kontogiorgis CA; Hadjipavlou-Litina D; Hamilakis S; Detsi A Bioorg Med Chem Lett; 2010 Jul; 20(13):3889-92. PubMed ID: 20627725 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety. Emami S; Foroumadi A; Faramarzi MA; Samadi N Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241 [TBL] [Abstract][Full Text] [Related]
9. Novel pyrazolo[3,4-d]pyrimidine-based inhibitors of Staphlococcus aureus DNA polymerase III: design, synthesis, and biological evaluation. Ali A; Taylor GE; Ellsworth K; Harris G; Painter R; Silver LL; Young K J Med Chem; 2003 May; 46(10):1824-30. PubMed ID: 12723946 [TBL] [Abstract][Full Text] [Related]
10. Antioxidant and antimicrobial studies on fused-ring pyrazolones and isoxazolones. Mazimba O; Wale K; Loeto D; Kwape T Bioorg Med Chem; 2014 Dec; 22(23):6564-6569. PubMed ID: 25456077 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel benzo[h]quinolines: wound healing, antibacterial, DNA binding and in vitro antioxidant activity. Naik HR; Naik HS; Naik TR; Naika HR; Gouthamchandra K; Mahmood R; Ahamed BM Eur J Med Chem; 2009 Mar; 44(3):981-9. PubMed ID: 18722035 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles. Abdel-Wahab BF; Abdel-Aziz HA; Ahmed EM Eur J Med Chem; 2009 Jun; 44(6):2632-5. PubMed ID: 18995932 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of new N-phenylpyrazole derivatives with potent antimicrobial activity. Farag AM; Mayhoub AS; Barakat SE; Bayomi AH Bioorg Med Chem; 2008 Apr; 16(8):4569-78. PubMed ID: 18313934 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activities of chiral 1,3-oxazinan-2-one derivatives. Wang G; Ella-Menye JR; Sharma V Bioorg Med Chem Lett; 2006 Apr; 16(8):2177-81. PubMed ID: 16495055 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles. Abdu Musad E; Mohamed R; Saeed BA; Vishwanath BS; Rai KM Bioorg Med Chem Lett; 2011 Jun; 21(12):3536-40. PubMed ID: 21612921 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives. Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure and antibacterial activity of new 2-(1-(2-(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-tetrahydroisoquinoline derivatives. Liu XH; Zhu J; Zhou AN; Song BA; Zhu HL; Bai LS; Bhadury PS; Pan CX Bioorg Med Chem; 2009 Feb; 17(3):1207-13. PubMed ID: 19147367 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of new 4-hydroxy bis-coumarins as radical scavengers and chain-breaking antioxidants. Kancheva VD; Boranova PV; Nechev JT; Manolov II Biochimie; 2010 Sep; 92(9):1138-46. PubMed ID: 20211681 [TBL] [Abstract][Full Text] [Related]
19. Detour of prenostodione synthesis towards pyrazolones for antibacterial activity. Rasapalli S; Fan Y; Yu M; Rees C; Harris JT; Golen JA; Jasinski JP; Rheingold AL; Kwasny SM; Opperman TJ Bioorg Med Chem Lett; 2013 Jun; 23(11):3235-8. PubMed ID: 23611730 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 3,5-substituted pyrazoles as possible antibacterial agents. Payne M; Bottomley AL; Och A; Asmara AP; Harry EJ; Ung AT Bioorg Med Chem; 2021 Oct; 48():116401. PubMed ID: 34555556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]